Lemaitre Vascular (LMAT) Tops Q4 EPS by 4c

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.13, $0.04 better than the analyst estimate of $0.09. Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.1 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform